Stock Movers Stock Movers: Diageo, DBV, HSBC (Podcast)
Dec 17, 2025
Louise Moon, a Bloomberg breaking news editor specializing in corporate deals and clinical trials, shares her insights on significant market movements. She discusses Diageo's $2.3 billion deal selling its stake in East African Breweries to Asahi, aimed at focusing on core operations. Moon also highlights DBV Technologies' promising trial results for a peanut allergy skin patch in children, and HSBC's stock rise after being upgraded, thanks to its strong Hong Kong operations and strategic turnaround efforts.
AI Snips
Chapters
Transcript
Episode notes
Diageo Sells African Brewing Assets
- Diageo sold its 65% stake in East African Breweries and related Kenya spirits assets to Asahi for $2.3 billion.
- The move fits Diageo's strategy of shedding non-core units to combat changing drinking habits and spur growth.
DBV Patch Shows Promising Trial Results
- DBV Technologies' redesigned peanut-allergy skin patch desensitised children aged four to seven in a key trial.
- The result restarts DBV's regulatory push in the U.S. and sent the stock sharply higher on the news.
Market Reacts Strongly To DBV Data
- DBV's shares soared and trading was halted after the positive trial outcome, reflecting strong market reaction.
- The stock had already risen about 80% since October ahead of the trial data.